Finished
Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors
NCT01281488 · City of Hope Medical Center · Updated 13 Oct 2017
- What is being tested
- fluorescence imaging; laparoscopic surgery; indocyanine green
- For
- Recurrent Renal Cell Cancer; Stage I Renal Cell Cancer; Stage II Renal Cell Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 1.
- Who can join
- Ages 18 years and older. About 28 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 20 Oct 2011, ends 9 Oct 2017. Registered 24 Jan 2011.
- Results
- None posted yet.
In the researchers' words
RATIONALE: Using fluorescence imaging may determine the extent of kidney tumors and help in planning surgery. PURPOSE: This phase I trial is studying the best way to give indocyanine green (ICG) fluorescence imaging in finding tumors in patients with kidney tumors
Sites
- City of Hope Medical CenterDuarte, California, United States